Vijay Ramanath, MD, FACC, FSCAI
Founder and Chief Medical Officer (CMO)
Ropana Vascular Founder.
Interventional Cardiologist with 15+ years of clinical expertise, with an entrepreneurial mindset and multiple patents.
Clinician-founded, with experienced commercialization leadership and an advisory board of leading vascular specialists.
Experienced leadership with decades of medical device and clinical experience.
Founder and Chief Medical Officer (CMO)
Ropana Vascular Founder.
Interventional Cardiologist with 15+ years of clinical expertise, with an entrepreneurial mindset and multiple patents.
Chief Executive Officer (CEO)
35 years of leadership in medical device sales, marketing and consulting to startups, scaleups and global corporations.
Chief Technology Officer (CTO)
A proven track record of delivering innovative medical devices that transform patient care. He has led teams to 18 clinical trials, 10 IDE approvals, and 3 PMA Class III approvals while driving two acquisitions exceeding $500M and mentoring high-performing R&D teams.
Chief Operating Officer (COO)
40 years of medical device leadership in strategic commercialization, operations and planning.
Leading interventional cardiologists, vascular medicine physicians and endovascular surgeons guide the FirstPass program.
Director of Vascular Medicine and the Interventional Vascular Laboratories at The Miriam and Rhode Island Hospitals
Dr. Soukas is also the director of the Vascular & Endovascular Medicine Fellowship Program. Dr. Soukas is a recognized expert on the interventional treatment of critical limb ischemia and endovascular treatment of both arterial and venous disease. He has delivered hundreds of invited lectures nationally and internationally and is a reviewer for several cardiovascular journals.
Director, Cardiac Catheterization and Interventional Cardiology, Hartford Healthcare Network
Dr. Craig Alan Thompson is known for specializing in complex coronary interventions (including chronic total occlusions), structural heart procedures such as TAVR, peripheral arterial disease, and catheter-based therapies.
Prior leadership roles include Senior Vice President and Chief Medical Officer for Interventional Cardiology at Boston Scientific (2014–2021).
Section Head, Vascular Medicine and Intervention, Massachusetts General Hospital
Kenneth Rosenfield, MD, MHCDS, MSCAI, is a leading interventional cardiologist and Section Head for Vascular Medicine and Intervention at Massachusetts General Hospital (with a faculty appointment at Harvard Medical School), specializing in complex cardiac and vascular procedures including carotid, renal, and peripheral artery disease, critical limb ischemia, and pulmonary embolism.
Interventional Cardiologist, Cardiovascular Institute of the South, Louisiana
Pradeep Nair, MD, FACC, FSCAI, is a board-certified interventional cardiologist at Cardiovascular Institute of the South in Louisiana, which he joined in 2015. His clinical focus includes peripheral arterial and venous disease and its interventional treatment.
Dr. Nair earned his medical degree at Drexel University College of Medicine and completed his internal medicine residency and cardiovascular and interventional cardiology fellowships at UPMC, followed by an advanced endovascular fellowship. He performs live endovascular cases at national meetings, researches novel interventional devices and therapies, and is Vice-Chairman of the New Cardiovascular Horizons Conference.
Co-founder, Pulse Cardiovascular Institute, Scottsdale, Arizona
Dr. Ramaiah is the co-founder of Pulse Cardiovascular Institute in Scottsdale, Arizona.
Dr. Ramaiah is a vascular and endovascular surgeon specializing in complex aortic aneurysms, peripheral arterial disease, carotid disease, and venous disorders, with more than 25 years of experience. He has authored over 90 peer-reviewed publications and textbook chapters, has served as principal investigator on multiple endovascular device trials, and has been recognized among America’s leading vascular surgeons.
Medical Director of Endovascular Therapy and Director of Cardiovascular Research, Michigan Outpatient Vascular Institute and Advanced Cardiac & Vascular Centers for Amputation Prevention
Dr. Saab, MD, FACC, FSCAI, FASE, is an interventional cardiologist specializing in endovascular revascularization for peripheral vascular disease and critical limb ischemia (CLI), as well as venous disease and general cardiac care.
Interventional Cardiologist, Houston, Texas
Karan S. Bhalla, MD, FACC, FSCAI, RPVI, is a board-certified interventional cardiologist specializing in cardiovascular diseases, coronary interventions, peripheral vascular disease, and related therapies, practicing in the southeast Houston area (Pasadena, Friendswood, and Houston).
CMO — Interventional Cardiologist, Plano/Frisco, Texas
Vijay S. Ramanath, MD, FACC, FSCAI, is a board-certified interventional cardiologist specializing in complex coronary procedures, peripheral vascular interventions (including techniques to prevent leg amputations), catheter-based therapies for blood clots, TAVR, and minimally invasive treatments for varicose veins.
Dr. Ramanath practices in the Plano/Frisco area of Texas.
Seasoned operators who help us build and commercialize.
Business and Strategy Advisor — veteran medical device executive
Terry is a veteran Med Device Executive who also rolls up his sleeves to get the work done.
Business and Strategy Advisor — serial entrepreneur
Bryan has built several businesses from the ground up, starting in the early 1990’s and continuing to the present.
To learn more about Ropana Vascular’s Regulatory and Development Pathway, connect with us.